These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3794330)

  • 41. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats.
    Tajima Y; Ichikawa S; Sakamaki T; Matsuo H; Aizawa F; Kogure M; Yagi S; Murata K
    Am J Physiol; 1983 May; 244(5):H695-700. PubMed ID: 6846557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats.
    Ziomber A; Machnik A; Dahlmann A; Dietsch P; Beck FX; Wagner H; Hilgers KF; Luft FC; Eckardt KU; Titze J
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1752-63. PubMed ID: 18842823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Separate hemodynamic roles for chloride and sodium in deoxycorticosterone acetate-salt hypertension.
    Passmore JC; Jimenez AE
    Proc Soc Exp Biol Med; 1990 Jul; 194(3):283-8. PubMed ID: 2356192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension.
    Jeffries WB; McArdle S; Bockman C; Abel PW; Pettinger WA
    Hypertension; 1991 Jan; 17(1):63-71. PubMed ID: 1846120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF; Rossoni LV
    J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of hypertension in animals with reduced total peripheral resistance.
    Huang M; Hester RL; Coleman TG; Smith MJ; Guyton AC
    Hypertension; 1992 Dec; 20(6):828-33. PubMed ID: 1452299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H15-21. PubMed ID: 8342627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
    Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats.
    Soltis EE; Field FP
    Hypertension; 1986 Nov; 8(11):1032-9. PubMed ID: 2429928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.